A new study published in The Spine Journal examines fusion rate for standalone anterior lumbar interbody fusions.

New York Attorney General Letitia James is suing New York City-based Park Avenue Stem Cell alleging the clinic performed unproven and rogue procedures on patients, the New York Times reports.

A new study published in the Journal of Neurosurgery: Spine examines the role of BMP use during spinal deformity cases.

The Journal of Neurosurgery published an article outlining "awake spinal fusion" using the endoscopic transforaminal lumbar interbody fusion technique without general anesthesia.

InVivo Therapeutics reported raising net proceeds of $16.5 million in 2018 and implemented significant cost savings measures last year.

Bioventus launched Osteoamp Select Fibers for use with its bone graft substitutes for spine, foot, ankle orthopedic and trauma surgeons.

Using the bone morphogenetic protein rhBMP-2 in the disc space for minimally invasive transforaminal lumbar interbody fusion led to a 97.9 percent fusion rate, according to a study in Clinical Spine Surgery.

The global spinal biologics market is projected to grow at a 3.6 percent compound annual growth rate to reach $2.55 billion by 2024, according to a Market Study Report.

Here are 13 key players in the global non-metal orthopedic biomaterial market, according to a Markets N Research report.

AlloSource enrolled the first patient in a study of its ProChondrix CR for articular cartilage defect repair.

The FDA cleared Atreon Orthopedics' Rotium Bioresorbable Wick for healing rotator cuff injuries.

Barbara A. Binzak Blumenfeld, PhD, is a shareholder at Buchanan Ingersoll & Rooney. She focuses her practice on the regulation of biologic research, and recently spoke with Becker’s Spine Review about where regenerative medicine is headed. 

Regenerative medicine company CollPlant renewed its exclusive distribution agreement with Arthrex for its soft tissue repair product Vergenix STR.

Regenerative medicine company IMAC Holdings has a new brand ambassador in former Chicago Bears coach Mike Ditka.

Structural allograft may be superior to intervertebral cages in anterior cervical discectomy and fusion, according to a study in Spine.

SpinalCyte was issued new patents in the U.S. and Japan.

The International Society for the Advancement of Spine Surgery issued a new bone grafting policy that includes Cerapedics' i-FACTOR Peptide Enhanced Bone Graft.

Aesculap Biologics achieved 50 percent enrollment in its ongoing phase 3 clinical trial of Novocart 3D, an autologous chondrocyte transplantation system designed to treat articular cartilage defects of the knee.

The global autologous matrix-induced chondrogenesis market is expected to grow at an 8.6 percent compound annual growth rate by 2024, according to a Persistence Market Research report.

Roger Hartl, MD, professor of neurological surgery and director of spine surgery at Weill Cornell Medicine in New York City, as well as director of the Weill Cornell Medicine Center for Comprehensive Spine Care, discusses the key trends in spine technology to consider in the future.